Pharmaceutical and Medical Device
King & Spalding’s Pharmaceutical & Medical Device practice is consistently recognized as among the best in the nation. Our knowledge of the industry, combined with our broad capabilities and a deep bench of first-chair trial attorneys, allow us to handle any aspect of drug and device litigation, from early case assessment, through discovery, and on to trial and exit strategies.
June 30, 2026
FDA Signals Greater Flexibility for Single-Trial Drug Approvals
March 9, 2026
EUROPE – Revision of the EU General Pharmaceutical Legislation – Regulatory Protections
January 9, 2026
FDA Updates General Wellness and Clinical Decision Support Guidance Documents
June 25, 2026
Partners Saranya Raghavan and Brian Nisbet join the firm’s Business Litigation practice group in Chicago
June 25, 2026
King & Spalding Continues Expansion of Complex Commercial and IP Litigation Capabilities, Adding Two Partners in Chicago
June 7, 2026
King & Spalding Secures Significant Summary Judgment Victory for Boehringer Ingelheim in Zantac-Related Litigation